Table 1. Characteristics of immunogenic peptides.

Peptide	Sequence	Cluster Address	Location	% Reactive Donors	SI* Average ± SD
A1	NAQFHYLYRSGFCIHVQ	164–180	VP2	50	2.8±3.3
A2	ADGFELQHPYVLDAGISISQL	224–244	VP2	16.7	1.1±1.0
A3	PHQWINLRTNNCATII	248–263	VP2	100	29.8±18.2
A4	HCNFGLLVVPISPLD	278–292	VP2	50	1.8±1.5
A6	TGSFMATGKMLIAYTPPGGPLP	445–466	VP3	16.7	2.5±3.4
A7	IWDFGLQSSVTLVIPWISNTH	479–499	VP3	33.3	1.1±1.2
A8	NTAYIIALAAAQKNFTMKL	533–551	VP3	83.3	7.3±3.7
A9	SLAWQTATNPSVFVK	733–747	VP1	33.3	1.5±0.9
A11	NQNYLFKANPNYAGNSI	833–849	VP1	16.7	1.5±1.4
A12	SRDLLVSSTTAQGCDT	899–914	VP1	16.7	1.1±1.0
A13	HYPVSFSKPSLIYVE	933–947	VP1	50	1.9±1.3
A14	SREVEALKNYFIGSE	1034–1048	2A	66.7	2.8±1.1
A19	GLEWVSNKISKFIDWL	1128–1143	2B	33.3	1.1±1.7
A30	DSVYLRMAFGHLYETF	1914–1929	3D	50	1.4±1.6
A31	GHLYETFHANPGTITGSA	1923–1940	3D	16.7	0.2±1.1

^*SI represents the fold increase in number of spot-forming cells over background.